4//SEC Filing
Scopa James Paul 4
Accession 0001610717-24-000101
CIK 0001799448other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 5:34 PM ET
Size
7.6 KB
Accession
0001610717-24-000101
Insider Transaction Report
Form 4
Scopa James Paul
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2024-02-27−30,000→ 0 totalExercise: $29.10From: 2021-05-26Exp: 2031-04-26→ Common Stock (30,000 underlying) - Award
Stock Option (Right to Buy)
2024-02-28+8,823→ 8,823 totalExercise: $0.96Exp: 2031-04-26→ Common Stock (8,823 underlying)
Footnotes (2)
- [F1]On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's shares granted to the reporting person on April 26, 2021. In exchange, on February 28, 2024, the reporting person received a replacement option, for 8,823 shares, having an exercise price of $0.96 per share.
- [F2]The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001356950
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 5:34 PM ET
- Size
- 7.6 KB